2025-10-01 REL RCSB INITIAL_RELEASE REPOSITORY DATABASE_REFERENCES citation em_admin _citation.journal_volume _citation.page_first _citation.page_last _em_admin.last_update RCSB RCSB 2025-05-26 2025-09-17 2025-09-17 2025-10-01 Not funded Tetrameric POLQ Helicase-like Domain Bound to Cmpd 19, a Small-Molecule ATPase Inhibitor and Drug Candidate Analog Zahn KE Scapin G Theta-mediated end-joining DNA-dependent ATPase DNA repair Inhibitor co-complex, DNA BINDING PROTEIN Mochirian P Papp R Mathieu MC Ferraro GB Dietrich E Liu B Bendahan D Perryman AL Surprenant S Fournier S Barzili BL Bonneau-Fortin A Yin SY Leclaire ME Patel C Poirier H Save S Mathieu Y Morin N Godbout C Burston HE Zahn KE Attia MA Pinter T Barabe F Parikh P Jagani C Kang G Scapin G Mamane Y Sfeir A Mader P Sicheri F Zimmermann M Roulston A Morris SJ Black WC Gallant M The Discovery of RP-2119: A Potent, Selective, and Orally Bioavailable Pol theta ATPase Inhibitor. J.Med.Chem. US 68 19726 19745 2025 40920169 doi:10.1021/acs.jmedchem.5c02103 0022-2623 0151 JMCMAR 9osw FULLOVERLAP EMDB EMD-70812 associated EM volume
Tetrameric POLQ Helicase-like Domain Bound to Cmpd 20, a Small-Molecule ATPase Inhibitor and Drug Candidate Analog
 Polymerase theta N-terminal domain in complex with ATPase inhibitor compound Polymerase theta N-terminal domain in complex with ATPase inhibitor compound 0 1 Homo sapiens 0.4 DNA polymerase theta Homo sapiens 0.100884812 4 Escherichia coli LEVO MNLLRRSGKRRRSESGSDSFSGSGGDSSASPQFLSGSVLSPPPGLGRCLKAAAAGECKPTVPDYERDKLLLANWGLPKAV LEKYHSFGVKKMFEWQAECLLLGQVLEGKNLVYSAPTSAGKTLVAELLILKRVLEMRKKALFILPFVSVAKEKKYYLQSL FQEVGIKVDGYMGSTSPSRHFSSLDIAVCTIERANGLINRLIEENKMDLLGMVVVDELHMLGDSHRGYLLELLLTKICYI TRKSASCQADLASSLSNAVQIVGMSATLPNLELVASWLNAELYHTDFRPVPLLESVKVGNSIYDSSMKLVREFEPMLQVK GDEDHVVSLCYETICDNHSVLLFCPSKKWCEKLADIIAREFYNLHHQAEGLVKPSECPPVILEQKELLEVMDQLRRLPSG LDSVLQKTVPWGVAFHHAGLTFEERDIIEGAFRQGLIRVLAATSTLSSGVNLPARRVIIRTPIFGGRPLDILTYKQMVGR AGRKGVDTVGESILICKNSEKSKGIALLQGSLKPVRSCLQRREGEEVTGSMIRAILEIIVGGVASTSQDMHTYAACTFLA ASMKEGKQGIQRNQESVQLGAIEACVMWLLENEFIQSTEASDGTEGKVYHPTHLGSATLSSSLSPADTLDIFADLQRAMK GFVLENDLHILYLVTPMFEDWTTIDWYRFFCLWEKLPTSMKRVAELVGVEEGFLARCVKGKVVARTERQHRQMAIHKRFF TSLVLLDLISEVPLREINQKYGCNRGQIQSLQQSAAVYAGMITVFSNRLGWHNMELLLSQFQKRLTFGIQRELCDLVRVS LLNAQRARVLYASGFHTVADLARANIVEVEVILKNAVPFKSARKAVDEEEEAVEERRNMRTIWVTGRKGLTEREAAALIV EEARMILQQDLVEMGVQWNPCALL O75417 3.6.4.12 (3M)-2'-chloro-N-{5-[(1S,2S)-2-(4-cyanophenyl)cyclopropyl]-1,3,4-thiadiazol-2-yl}-5'-methoxy[3,4'-bipyridine]-4-carboxamide 0.000488949 4 A1CER singleParticle particle 1.0 7.5
20 mM HEPES pH 7.5, 300 mM NaCl, 1 mM TCEP, 5% glycerol
 UltrAuFoil PLASMA CLEANING ETHANE
3 microL drop of sample suspension is applied to an EM grid that has been plasma-cleaned using a Gatan Solarus. After blotting the sample away with filter paper, grids are plunge-frozen in liquid ethane. Grids are stored under liquid nitrogen until transferred to the transmission electron microscope for imaging..
POLQ-ATPase + RP-11203 compound were mixed on ice in buffer to a final concentration of 1.00 mg/mL protein and 2x molar equivalents of the inhibitor compound
 TFS KRIOS FLOOD BEAM BRIGHT FIELD FIELD EMISSION GUN 300 1.2 1.8 105000.0 GATAN K3 (6k x 4k) 15749 50.0 1
~14.5M particles were initially selected from 14,375 manually curated micrographs using cryoSPARC 3.1 live. All subsequent data processing was carried out in cryoSPARC 3.1.These particles were subjected to 3 rounds of 2D classification. A subset of particles from the final round of 2D classification were used to train the Deep Learning particle picker Topaz (as implemented in cryoSPARC 3.1). The Topaz trained model was used to re-extract particles from the 14,375 micrographs, yielding a new particle set comprising ~7M particles.
 PHASE FLIPPING AND AMPLITUDE CORRECTION 5AGA 2.67 FSC 0.143 CUT-OFF 674000 MAXIMUM LIKELIHOOD MAXIMUM LIKELIHOOD emd_70812.map.gz 1 IMAGE STORED AS FLOATING POINT NUMBER (4 BYTES) 360 360 360 0 0 0 360 360 360 297.0 297.0 297.0 90.0 90.0 90.0 X Y Z -0.6619957 1.1047114 0.00047776726 0.024284532 0.825 0.825 0.825 0.085 AUTHOR Sharpened map 5AGA PDB experimental model FLEXIBLE FIT CC_mask: 0.8076 REAL 76.400000000000006 emd_70812_additional_1.map.gz 1 IMAGE STORED AS FLOATING POINT NUMBER (4 BYTES) 360 360 360 0 0 0 360 360 360 297.0 297.0 297.0 90.0 90.0 90.0 X Y Z -0.19511513 0.3905491 0.00047776726 0.011598603 0.825 0.825 0.825 AUTHOR For the unsharpened map, a contour level of was selected to enclose a similar molecular volume, based on visual inspection and volumetric measurement in UCSF Chimera. emd_70812_half_map_2.map.gz 1 IMAGE STORED AS FLOATING POINT NUMBER (4 BYTES) 360 360 360 0 0 0 360 360 360 297.0 297.0 297.0 90.0 90.0 90.0 X Y Z -0.29595026 0.49642262 0.0005082768 0.035602354 0.825 0.825 0.825 AUTHOR Half map B emd_70812_half_map_1.map.gz 1 IMAGE STORED AS FLOATING POINT NUMBER (4 BYTES) 360 360 360 0 0 0 360 360 360 297.0 297.0 297.0 90.0 90.0 90.0 X Y Z -0.2933713 0.47490823 0.00051331474 0.035732865 0.825 0.825 0.825 AUTHOR Half map A